Publication | Closed Access

The tamoxifen metabolite norendoxifen is a potent and selective inhibitor of aromatase (CYP19) and a potential lead compound for novel therapeutic agents

Medicinal ChemistryEndocrine-related CancerBiochemistryMedicinePotential Lead CompoundNatural SciencesNovel Therapeutic AgentsAromatasePharmacotherapyTamoxifen Metabolite NorendoxifenAnti-cancer AgentMetabolomicsPharmacologySteroid MetabolismDrug Discovery